While there are already several medications and treatments on the market for relapsing multiple sclerosis there continues to be a concerted effort to develop more in an effort to help as many patients as possible.
Patients with multiple sclerosis are no strangers to taking medication for their condition at various times. A new autoinjector recently approved by the FDA hopes to help patients with that process with updated technology and other features to make the process more streamlined and less painful.
October has been pinpointed as the start of flu season in the United States. So if prevention of the contagious illness isn’t enough to convince patients to get their influenza vaccine, a new analysis involving stroke risk just might.